Loading stock data...
Last Updated: 10 Mar 2026, 03:30:03 PM (IST)

MedPlus Health Services Limited

NSE: MEDPLUS BSE: MEDPLUS

NSE
830.35 5.00 (0.61%)

Prev Close

825.35

Open Price

830

Volume

76,499

Today Low / High

826.55 / 844

52 WK Low / High

678.05 / 1045.3

Range

789 - 872

BSE
832.95 7.05 (0.85%)

Prev Close

825.9

Open Price

832.5

Volume

1,273

Today Low / High

825.8 / 843.25

52 WK Low / High

603 / 1052.05

Range

791 - 875

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 830.35 (target range: 789 - 872), reflecting a change of 5 (0.6058%). On the BSE, it is listed at 832.95 (target range: 791 - 875), showing a change of 7.05 (0.85361%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

02 Mar 802.60 4.64%
27 Feb 847.05 0.06%
26 Feb 850.90 -0.26%
25 Feb 835.90 2.26%
24 Feb 829.00 0.73%
23 Feb 829.15 0.73%
20 Feb 834.10 -0.59%
19 Feb 845.55 -1.78%
18 Feb 846.50 0.02%

MedPlus Health Services Limited Graph

MedPlus Health Services Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for MedPlus Health Services Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 830.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 832.95 841.28 757.15 - 925.41
849.61 679.69 - 1,019.53
857.94 600.56 - 1,115.32
Bearish Scenario 832.95 824.62 742.16 - 907.08
816.29 653.03 - 979.55
807.96 565.57 - 1,050.35

Overview of MedPlus Health Services Limited

ISIN

INE804L01022

Industry

Medical - Pharmaceuticals

Vol.Avg

118,472

Market Cap

100,784,839,533

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-12-23

DCF Diff

223.15

DCF

610

Financial Ratios Every Investor Needs

Stock Rating Details for MEDPLUS

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6,136.05 Cr 4,665.57 Cr 1,470.49 Cr 0.2396 0.00 Cr 726.15 Cr 726.43 Cr 150.32 Cr 12.57 323.87 Cr 0.0245
2024-03-31 5,624.86 Cr 4,410.52 Cr 1,214.34 Cr 0.2159 0.00 Cr 625.62 Cr 563.51 Cr 65.47 Cr 5.48 208.46 Cr 0.0116
2023-03-31 4,557.58 Cr 3,575.78 Cr 981.79 Cr 0.2154 0.00 Cr 545.26 Cr 425.28 Cr 49.76 Cr 4.17 141.15 Cr 0.0109
2022-03-31 3,779.28 Cr 2,993.80 Cr 785.48 Cr 0.2078 0.00 Cr 394.17 Cr 384.53 Cr 95.80 Cr 8.55 186.72 Cr 0.0253
2021-03-31 3,069.27 Cr 2,431.41 Cr 637.86 Cr 0.2078 0.00 Cr 338.83 Cr 297.35 Cr 63.86 Cr 6.13 152.00 Cr 0.0208

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 86.05 Cr 3,360.10 Cr 1,620.20 Cr 1,740.5610 Cr 1,119.80 Cr 752.58 Cr 1,345.10 Cr 1,261.75 Cr 0.00 Cr 0.00 Cr 2.36 Cr 576.5940 Cr
2024-03-31 91.21 Cr 3,004.80 Cr 1,427.44 Cr 1,577.9320 Cr 1,009.57 Cr 918.36 Cr 1,340.23 Cr 1,202.69 Cr 15.77 Cr 0.00 Cr 5.10 Cr 525.9350 Cr
2023-03-31 228.38 Cr 2,796.72 Cr 1,306.22 Cr 1,491.1780 Cr 904.88 Cr 676.51 Cr 1,144.09 Cr 1,114.44 Cr 9.34 Cr 0.00 Cr 2.21 Cr 476.5830 Cr
2022-03-31 21.46 Cr 2,594.05 Cr 1,176.80 Cr 1,417.7720 Cr 814.94 Cr 793.48 Cr 914.98 Cr 771.48 Cr 85.33 Cr 0.00 Cr -566.96 Cr 559.0120 Cr
2021-03-31 106.82 Cr 1,565.66 Cr 834.55 Cr 730.5530 Cr 590.21 Cr 483.40 Cr 749.96 Cr 477.58 Cr 71.04 Cr 0.00 Cr -42.28 Cr 414.9400 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 554.4070 Cr -331.6450 Cr -227.9190 Cr 494.9570 Cr 276.0090 Cr 367.2180 Cr -59.4500 Cr 150.3220 Cr -130.0240 Cr 0.0000 Cr -4.8650 Cr
2024-03-31 143.7370 Cr -82.7990 Cr -198.1040 Cr 59.3380 Cr -137.1660 Cr 91.2090 Cr -84.3990 Cr 65.4730 Cr -108.9020 Cr 0.0000 Cr -196.1470 Cr
2023-03-31 90.4100 Cr 429.4410 Cr -170.2490 Cr -78.5950 Cr 349.6020 Cr 228.3750 Cr -169.0050 Cr 47.1630 Cr -88.4110 Cr 0.0000 Cr -229.1030 Cr
2022-03-31 169.8890 Cr -703.1260 Cr 440.4290 Cr 52.1680 Cr -92.8080 Cr -121.2270 Cr -117.7210 Cr 117.9430 Cr -65.6380 Cr 0.0000 Cr -165.0270 Cr
2021-03-31 2.8910 Cr -34.5490 Cr -5.6260 Cr -51.3670 Cr -37.2840 Cr -28.4190 Cr -54.2580 Cr 95.0980 Cr -95.3150 Cr 0.0000 Cr -106.4020 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 1,806.12 Cr 1,639.07 Cr 167.05 Cr 0.0925 85.88 Cr 57.81 Cr 4.83 176.86 Cr 0.0320
2025-09-30 1,679.33 Cr 1,522.14 Cr 157.19 Cr 0.0936 80.29 Cr 55.50 Cr 4.63 166.32 Cr 0.0330
2025-06-30 1,542.63 Cr 1,139.74 Cr 402.90 Cr 0.2612 202.46 Cr 42.36 Cr 3.54 84.39 Cr 0.0275
2025-03-31 1,509.61 Cr 1,133.54 Cr 376.07 Cr 0.2491 163.86 Cr 51.34 Cr 4.32 103.55 Cr 0.0340
2024-12-31 1,561.45 Cr 1,170.58 Cr 390.86 Cr 0.2503 201.18 Cr 45.89 Cr 3.84 86.60 Cr 0.0294

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 209.78 Cr 292.13 Cr 501.91 Cr 18.09 Cr 1,280.74 Cr 1,965.04 Cr 1,321.94 Cr 3,572.22 Cr 1,727.89 Cr
2025-06-30 0.00 Cr 0.00 Cr 367.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,739.90 Cr
2025-03-31 367.22 Cr 0.00 Cr 367.22 Cr 13.27 Cr 1,345.10 Cr 1,843.52 Cr 1,261.75 Cr 3,360.10 Cr 1,620.20 Cr
2024-12-31 0.00 Cr 0.00 Cr 267.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,635.67 Cr
2024-09-30 123.97 Cr 179.09 Cr 303.07 Cr 17.98 Cr 1,340.71 Cr 1,712.39 Cr 1,190.99 Cr 3,155.07 Cr 1,519.40 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 42.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 51.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 45.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 38.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 14.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹830.35 ₹99,644,807,413.00 ₹76,499.00

Key Executives

Chief Operating Officer & Whole Time Director
Cherukupalli Bhaskar Reddy

Gender: Not Specified

Year Born: 1968

Founder, Chief Executive Officer, MD & Chairman
Gangadi Madhukar Reddy

Gender: Not Specified

Year Born: 1967

Head of Supply Chain
Kandasamy Vairaperumal

Gender: male

Year Born:

Head of Corporate Secretarial & Governance, Company Secretary and Compliance Officer
Manoj Kumar Srivastava

Gender: male

Year Born:

Chief Technology Officer
Subrahmanyam Sharma Tatapudi

Gender: male

Year Born:

Chief Financial Officer
Sujit Kumar Mahato

Gender: male

Year Born:

FAQs about MedPlus Health Services Limited

Who is the CEO of the company?

The CEO is Gangadi Madhukar Reddy.

What is the current market price of the stock?

The current price is ₹839.85.

What is the 52-week price range?

The range is ₹678.05-1045.3.

What is the market capitalization of the company?

The market capitalization is ₹10,078.48 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 48.59.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of MedPlus Health Services Limited (ISIN: INE804L01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10,078.48 crores and an average daily volume of 118,472 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.